John F Mauldin - Net Worth and Insider Trading

John F Mauldin Net Worth

The estimated net worth of John F Mauldin is at least $69,063 dollars as of 2024-11-10. John F Mauldin is the Director of Galectin Therapeutics Inc and owns about 23,021 shares of Galectin Therapeutics Inc (GALT) stock worth over $69,063. Details can be seen in John F Mauldin's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John F Mauldin has not made any transactions after 2014-01-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of John F Mauldin

To

John F Mauldin Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, John F Mauldin owns 2 companies in total, including AgeX Therapeutics Inc (AGE) , and Galectin Therapeutics Inc (GALT) .

Click here to see the complete history of John F Mauldin’s form 4 insider trades.

Insider Ownership Summary of John F Mauldin

Ticker Comapny Transaction Date Type of Owner
AGE AgeX Therapeutics Inc 2018-11-27 director
GALT Galectin Therapeutics Inc 2014-01-02 director

John F Mauldin Latest Holdings Summary

John F Mauldin currently owns a total of 1 stock. John F Mauldin owns 23,021 shares of Galectin Therapeutics Inc (GALT) as of January 2, 2014, with a value of $69,063.

Latest Holdings of John F Mauldin

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
GALT Galectin Therapeutics Inc 2014-01-02 23,021 3.00 69,063

Holding Weightings of John F Mauldin


John F Mauldin Form 4 Trading Tracker

According to the SEC Form 4 filings, John F Mauldin has made a total of 0 transactions in Galectin Therapeutics Inc (GALT) over the past 5 years. The most-recent trade in Galectin Therapeutics Inc is the acquisition of 618 shares on January 2, 2014, which cost John F Mauldin around $4,950.

Insider Trading History of John F Mauldin

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

John F Mauldin Trading Performance

GuruFocus tracks the stock performance after each of John F Mauldin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John F Mauldin is 71.94%. GuruFocus also compares John F Mauldin's trading performance to market benchmark return within the same time period. The performance of stocks bought by John F Mauldin within 3 months outperforms 8 times out of 9 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how John F Mauldin's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of John F Mauldin

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
3 out of 9 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 24.6 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 22.96 LIMIT LIMIT LIMIT LIMIT LIMIT

John F Mauldin Ownership Network

Ownership Network List of John F Mauldin

No Data

Ownership Network Relation of John F Mauldin

Insider Network Chart

John F Mauldin Owned Company Details

What does AgeX Therapeutics Inc do?

Who are the key executives at AgeX Therapeutics Inc?

John F Mauldin is the director of AgeX Therapeutics Inc. Other key executives at AgeX Therapeutics Inc include director & 10 percent owner Juvenescence Us Corp. , Chief Financial Officer Park Andrea Eun Jae , and director & Chief Executive Officer Michael D West .

AgeX Therapeutics Inc (AGE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of AgeX Therapeutics Inc (AGE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AgeX Therapeutics Inc (AGE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

AgeX Therapeutics Inc (AGE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

AgeX Therapeutics Inc Insider Transactions

No Available Data

John F Mauldin Mailing Address

Above is the net worth, insider trading, and ownership report for John F Mauldin. You might contact John F Mauldin via mailing address: 3204 Beverly Drive, Dallas Tx 75205.